Trial Profile
A trial to study the effect of INT-301 in peanut-hypersensitivity
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs INT 301 (Primary)
- Indications Peanut hypersensitivity
- Focus Adverse reactions
- 08 Jun 2016 New trial record